Intravenous Solution Market 2018 to 2022, With Eminent Players as ICU Medical,, B. Braun Melsungen, Fresenius Kabi, Baxter, Amanta Healthcare, etc. By MRFR

Market Research Future has a cooked research report on analysis of the market structure along with forecast for the next seven years of the various segments and sub-segments of the “Intravenous Solution Market”.

Intravenous Solution (IV) Market - Scenario

According to a study report published by Market Research Future (MRFR), the global intravenous solutions market for is poised to grow at a CAGR of 7.69% from 2016 to 2022 (forecast period). It can attain a valuation of USD 11,511.2 Mn by 2022. Intravenous (IV) therapy involves the infusion of therapeutic solution into the vein, and it is ideal for patients suffering from nutrition deficiency or severe dehydration. IV therapy is used to treat electrolyte imbalances, deliver medications, transfuse blood or correct dehydration and might also be used for chemotherapy.  Intravenous therapy is widely believed to be more effective than oral ingestion. Intravenous fluids are manufactured by pharmaceutical companies and their use and demand is increasing gradually.

Request Premium Sample copy at https://www.marketresearchfuture.com/sample_request/1235

The factors which drive the market for intravenous (IV) solutions are cost-effectiveness, increasing prevalence of chronic diseases, the rise of cholera, and growing acceptance of vitamin C intravenous for colorectal cancer, rise in geriatric population, increase in number of dialysis patients, expanding healthcare expenditure and increasing government endorsement. Successive changes in regulatory authorities’ reimbursement policies have motivated hospitals to explore different methods of administering drugs through the intravenous process. Growing adoption of intravenous solutions has spurred the growth of the market, and it is expected that the market will advance with high growth rate, however, stringent government regulations might hinder the growth of the market. IV solutions are manufactured under very rigorous guidelines to ensure patient safety. Increasing vitamin C intravenous therapy prices might also hamper the growth.

Competitive Dashboard:

The global intravenous solutions market is experiencing a period of competition and innovation. To stay competitive, the industry participants are broadening their product lines, entering into mergers, partnerships, implementing strategies such as collaborations and acquisitions, which in turn is further driving the market.

The Renowned Market players include:

ICU Medical

Fresenius Kabi AG

Amanta Healthcare

Grifols S.A.

B. Braun Melsungen AG

Baxter

Terumo Medical Corporation and others.

Intravenous (IV) Solution Market - Segmentation:

The global intravenous (IV) solutions market has been segmented based on type, nutritional content and end-user. By type, the market has been segmented into total parenteral solution and peripheral parenteral solution. According to MRFR analysis, by type, total parenteral nutrition (TPN) held the maximum market share of the IV solutions market and had attained USD 4,940.0 million in 2016.  By nutritional content, the market has been segmented into amino acid solutions, vitamins & minerals, parenteral lipid emulsion, carbohydrates and others. The amino acid solution segment held the maximum market share and had attained USD 2,385.0 million in 2016. By end-users, the market has been segmented into hospitals & clinics, homecare and ambulatory.

Get Customized Report with niche Segments, Vital Players and Overall Segments at https://www.marketresearchfuture.com/enquiry/1235

Intravenous (IV) Solution Market - Regional Analysis:

The key markets of the global intravenous (IV) solutions market include North America, Europe, Asia-pacific and the Middle East & Africa. The IV solutions market in North America holds the most significant share of the market and it attained USD 4,276.5 million in 2016. The growth can be attributed to the high adoption of IV therapy and high prevalence of chronic diseases in the region.

The Asia-Pacific market is projected to garner a CAGR of 8.34% during the forecast period. The region is expected to be the fastest growing market owing to increasing health awareness about infusion, increasing government focus on IV therapy and rising per capita income. The Middle East and Africa region offer potential export opportunities for local producers, but the market is relatively smaller compared to other regions.

Industry Trends/Updates:

In May 2018, JW Holdings, a Korean company, announced export deals with Brazil-based Sif Participacoe and India's Alniche Lifescience. In the five year contract, the company will be exporting IV solutions and five other medications.

Get Prime Discount at https://www.marketresearchfuture.com/check-discount/1235

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

This release was published on openPR.